General Updates

Aurobindo Pharma Limited has announced that it has received the necessary approval from the US Federal Trade Commission (FTC) for its acquisition of the Lannett business. This approval pertains to Aurobindo Pharma USA Inc., a wholly-owned subsidiary, acquiring 100% of the membership interest in Lannett Company LLC. This marks a crucial step forward for the previously announced acquisition. For investors, this signifies the removal of a major regulatory hurdle, paving the way for the completion of the transaction.